Treatment of infections of the digestive and respiratory tracts caused by enrofloxacin susceptible strains of: Escherichia coli, Pasteurella multocida and Staphylococcus spp. Treatment of skin and wound infections caused by enrofloxacin susceptible strains of Staphylococcus aureus. Rodents, reptiles and ornamental birds Treatment of infections of the digestive and respiratory tracts where clinical experience, if possible, supported by susceptibility testing of the causal organism, indicates enrofloxacin as the substance of choice.